Diabetes Metab J. 2020;44(2):248-259.
Glucagon-Like Peptide-1 Receptor Agonist Differentially Affects Brain Activation in Response to Visual Food Cues in Lean and Obese Individuals with Type 2 Diabetes Mellitus.
제1저자 배재현, 최형진 · 교신저자 조영민
소속 (10)
- Department of Medicine, Seoul National University College of Medicine, Seoul, Korea.
- Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
- Department of Anatomy, Seoul National University College of Medicine, Seoul, Korea.
- Neuroscience Research Institute, Seoul National University, Seoul, Korea.
- Wide River Institute of Immunology, Seoul National University, Seoul, Korea.
- Department of Brain and Cognitive Sciences, Seoul National University College of Natural Sciences, Seoul, Korea.
- Institute of Human Behavioral Medicine, Seoul National University Medical Research Center, Seoul, Korea.
- Department of Internal Medicine, Cheju Halla General Hospital, Jeju, Korea.
- Department of Psychiatry, Seoul National University College of Medicine, Seoul, Korea.
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. ymchomd@snu.ac.kr.
Abstract
BACKGROUND To investigate the effects of a glucagon-like peptide-1 receptor agonist on functional brain activation in lean and obese individuals with type 2 diabetes mellitus (T2DM) in response to visual food cues.
METHODS In a randomized, single-blinded, crossover study, 15 lean and 14 obese individuals with T2DM were administered lixisenatide or normal saline subcutaneously with a 1-week washout period. We evaluated brain activation in response to pictures of high-calorie food, low-calorie food, and nonfood using functional magnetic resonance imaging and measured appetite and caloric intake in participants who were given access to an ad libitum buffet.
RESULTS Obese individuals with T2DM showed significantly greater activation of the hypothalamus, pineal gland, parietal cortex (high-calorie food vs. low-calorie food, P<0.05), orbitofrontal cortex (high-calorie food vs. nonfood, P<0.05), and visual cortex (food vs. nonfood, P<0.05) than lean individuals with T2DM. Lixisenatide injection significantly reduced the functional activation of the fusiform gyrus and lateral ventricle in obese individuals with T2DM compared with that in lean individuals with T2DM (nonfood vs. high-calorie food, P<0.05). In addition, in individuals who decreased their caloric intake after lixisenatide injection, there were significant interaction effects between group and treatment in the posterior cingulate, medial frontal cortex (high-calorie food vs. low-calorie food, P<0.05), hypothalamus, orbitofrontal cortex, and temporal lobe (food vs. nonfood, P<0.05).
CONCLUSION Brain responses to visual food cues were different in lean and obese individuals with T2DM. In addition, acute administration of lixisenatide differentially affected functional brain activation in these individuals, especially in those who decreased their caloric intake after lixisenatide injection.
Copyright © 2020 Korean Diabetes Association.
Keywords
AppetiteBrainDiabetes mellitus, type 2Energy intakeFunctional neuroimagingGlucagon-like peptide 1LixisenatideMagnetic resonance imagingObesity
Figures
그림 출처: PubMed Central 공개 논문 (PMC7188972)
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
그 밖의 정보
- 출판 형태
- Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- 저널
- Diabetes & metabolism journal · eISSN 2233-6087
- 전자 출판
- 2019-11-04
- MeSH
- Aged · Appetite / drug effects · Brain / diagnostic imaging / physiology · Brain Mapping / statistics & numerical data · Case-Control Studies · Cross-Over Studies · Cues · Diabetes Mellitus, Type 2 / drug therapy / epidemiology · Energy Intake / drug effects · Female · Food Preferences / physiology / psychology · Glucagon-Like Peptide-1 Receptor / metabolism · Humans · Hypoglycemic Agents / administration & dosage / pharmacology · Injections, Subcutaneous · Magnetic Resonance Imaging / methods · Male · Middle Aged · Obesity / physiopathology · Peptides / administration & dosage / pharmacology · Photic Stimulation / methods · Saline Solution / administration & dosage · Thinness / physiopathology · Glucagon-Like Peptide-1 Receptor Agonists* · Glucagon-Like Peptide-2 Receptor
- Substances
- Glucagon-Like Peptide-1 Receptor · Hypoglycemic Agents · Peptides · Saline Solution · Glucagon-Like Peptide-1 Receptor Agonists · lixisenatide · Glucagon-Like Peptide-2 Receptor
- 연구비
- KDA 2016S-1 · Seoul National University College of Medicine 800-20150083
- 참고문헌
- 66편